What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Protein tyrosine phosphatase, Signal transduction, Cell biology, Cancer research and Molecular biology.
The study incorporates disciplines such as Receptor tyrosine kinase and Tyrosine phosphorylation in addition to Protein tyrosine phosphatase.
His Cell biology research is multidisciplinary, incorporating elements of Suppressor of cytokine signaling 1 and Receptor.
The Cancer research study combines topics in areas such as Chronic myelogenous leukemia, K562 cells, ABL and PTPN11.
He combines subjects such as Gene expression, Transcription factor, RNA splicing, Spliceosome and Intron with his study of Molecular biology.
Benjamin G. Neel has included themes like Epidermal growth factor and Leptin, Leptin receptor in his Phosphorylation study.
His most cited work include:
- SH2 domains recognize specific phosphopeptide sequences (2506 citations)
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway (1785 citations)
- Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis (1171 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Protein tyrosine phosphatase, Cell biology, Cancer research, Signal transduction and Phosphorylation.
His studies in Protein tyrosine phosphatase integrate themes in fields like Phosphatase, Receptor tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and Molecular biology.
His Cell biology study combines topics from a wide range of disciplines, such as Receptor and Integrin.
His Cancer research study combines topics in areas such as Cancer, Protein kinase B, Juvenile myelomonocytic leukemia, MAPK/ERK pathway and PTPN11.
Benjamin G. Neel regularly ties together related areas like Endocrinology in his Signal transduction studies.
His biological study spans a wide range of topics, including Tyrosine and Insulin receptor, Insulin resistance.
He most often published in these fields:
- Protein tyrosine phosphatase (35.17%)
- Cell biology (38.08%)
- Cancer research (30.52%)
What were the highlights of his more recent work (between 2014-2020)?
- Cancer research (30.52%)
- Serous fluid (4.94%)
- Cancer (9.30%)
In recent papers he was focusing on the following fields of study:
Benjamin G. Neel mostly deals with Cancer research, Serous fluid, Cancer, Ovarian cancer and Ovarian carcinoma.
His work deals with themes such as Cancer cell, RNA splicing, Spliceosome, Organoid and Intron, which intersect with Cancer research.
His Cancer cell research incorporates themes from Transcription factor, Kinase, MAPK/ERK pathway and Triple-negative breast cancer.
Benjamin G. Neel interconnects RNA and Molecular biology in the investigation of issues within Intron.
The concepts of his Cancer study are interwoven with issues in Cell, Haematopoiesis, Immunology, Bone marrow and Receptor.
His Ovarian cancer research is within the category of Internal medicine.
Between 2014 and 2020, his most popular works were:
- The spliceosome is a therapeutic vulnerability in MYC-driven cancer (262 citations)
- The spliceosome is a therapeutic vulnerability in MYC-driven cancer (262 citations)
- Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. (249 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cancer research, Gene expression, Interactome, Phosphorylation and Signal transduction.
His study in Cancer research is interdisciplinary in nature, drawing from both Epithelium, RNA, Cancer cell, Oncogene and Cell type.
His Gene expression research integrates issues from Transcription factor, RNA splicing, Spliceosome, Molecular biology and Intron.
Benjamin G. Neel has researched Interactome in several fields, including Phosphatase, Receptor tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and Protein tyrosine phosphatase.
Benjamin G. Neel is interested in PTPRB, which is a field of Phosphorylation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
